 | • レポートコード：GIR-23F3865 • 出版社/出版日：GlobalInfoResearch / 2023年2月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Mono Vaccine Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のモノワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 モノワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱病ワクチン、肝炎ワクチン、コレラワクチン、その他 アプリケーション別セグメントは次のように区分されます。 ・大人、子供 世界のモノワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・GSK、Sanofi Pasteur、Merck、Pfizer、CNBG、Sanofi Pasteur MSD、Serum Institute of India、Biokangtai 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - モノワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱病ワクチン、肝炎ワクチン、コレラワクチン、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：大人、子供 - 世界のモノワクチン市場規模・予測 - 世界のモノワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GSK、Sanofi Pasteur、Merck、Pfizer、CNBG、Sanofi Pasteur MSD、Serum Institute of India、Biokangtai ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：髄膜炎菌ワクチン、日本脳炎ワクチン、黄熱病ワクチン、肝炎ワクチン、コレラワクチン、その他 ・アプリケーション別分析2017年-2028年：大人、子供 ・モノワクチンの北米市場分析 - モノワクチンの北米市場：タイプ別市場規模2017年-2028年 - モノワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・モノワクチンのヨーロッパ市場分析 - ：モノワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：モノワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・モノワクチンのアジア太平洋市場分析 - モノワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - モノワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・モノワクチンの南米市場分析 - モノワクチンの南米市場：タイプ別市場規模2017年-2028年 - モノワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・モノワクチンの中東・アフリカ市場分析 - モノワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - モノワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Mono Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mono Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adults accounting for % of the Mono Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Meningococcal Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mono Vaccine include GSK, Sanofi Pasteur, Merck, Pfizer, and CNBG, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mono Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other
Market segment by Application can be divided into
Adults
Children
The key market players for global Mono Vaccine market are listed below:
GSK
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mono Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mono Vaccine, with price, sales, revenue and global market share of Mono Vaccine from 2019 to 2022.
Chapter 3, the Mono Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mono Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mono Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mono Vaccine.
Chapter 13, 14, and 15, to describe Mono Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Mono Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mono Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Meningococcal Vaccine
1.2.3 Japanese Encephalitis Vaccine
1.2.4 Yellow Fever Vaccine
1.2.5 Hepatitis Vaccine
1.2.6 Cholera Vaccine
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Mono Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adults
1.3.3 Children
1.4 Global Mono Vaccine Market Size & Forecast
1.4.1 Global Mono Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mono Vaccine Sales in Volume (2017-2028)
1.4.3 Global Mono Vaccine Price (2017-2028)
1.5 Global Mono Vaccine Production Capacity Analysis
1.5.1 Global Mono Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Mono Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mono Vaccine Market Drivers
1.6.2 Mono Vaccine Market Restraints
1.6.3 Mono Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mono Vaccine Product and Services
2.1.4 GSK Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Mono Vaccine Product and Services
2.2.4 Sanofi Pasteur Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Mono Vaccine Product and Services
2.3.4 Merck Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Mono Vaccine Product and Services
2.4.4 Pfizer Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CNBG
2.5.1 CNBG Details
2.5.2 CNBG Major Business
2.5.3 CNBG Mono Vaccine Product and Services
2.5.4 CNBG Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi Pasteur MSD
2.6.1 Sanofi Pasteur MSD Details
2.6.2 Sanofi Pasteur MSD Major Business
2.6.3 Sanofi Pasteur MSD Mono Vaccine Product and Services
2.6.4 Sanofi Pasteur MSD Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Mono Vaccine Product and Services
2.7.4 Serum Institute of India Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biokangtai
2.8.1 Biokangtai Details
2.8.2 Biokangtai Major Business
2.8.3 Biokangtai Mono Vaccine Product and Services
2.8.4 Biokangtai Mono Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mono Vaccine Breakdown Data by Manufacturer
3.1 Global Mono Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mono Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mono Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Mono Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Mono Vaccine Manufacturer Market Share in 2021
3.5 Global Mono Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mono Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mono Vaccine Market Size by Region
4.1.1 Global Mono Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Mono Vaccine Revenue by Region (2017-2028)
4.2 North America Mono Vaccine Revenue (2017-2028)
4.3 Europe Mono Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Mono Vaccine Revenue (2017-2028)
4.5 South America Mono Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Mono Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mono Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Mono Vaccine Revenue by Type (2017-2028)
5.3 Global Mono Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mono Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Mono Vaccine Revenue by Application (2017-2028)
6.3 Global Mono Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mono Vaccine Sales by Type (2017-2028)
7.2 North America Mono Vaccine Sales by Application (2017-2028)
7.3 North America Mono Vaccine Market Size by Country
7.3.1 North America Mono Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Mono Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mono Vaccine Sales by Type (2017-2028)
8.2 Europe Mono Vaccine Sales by Application (2017-2028)
8.3 Europe Mono Vaccine Market Size by Country
8.3.1 Europe Mono Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Mono Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mono Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Mono Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Mono Vaccine Market Size by Region
9.3.1 Asia-Pacific Mono Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mono Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mono Vaccine Sales by Type (2017-2028)
10.2 South America Mono Vaccine Sales by Application (2017-2028)
10.3 South America Mono Vaccine Market Size by Country
10.3.1 South America Mono Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Mono Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mono Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Mono Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Mono Vaccine Market Size by Country
11.3.1 Middle East & Africa Mono Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mono Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mono Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mono Vaccine
12.3 Mono Vaccine Production Process
12.4 Mono Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mono Vaccine Typical Distributors
13.3 Mono Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Mono Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Mono Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Mono Vaccine Product and Services
Table 6. GSK Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur Mono Vaccine Product and Services
Table 10. Sanofi Pasteur Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Mono Vaccine Product and Services
Table 14. Merck Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Mono Vaccine Product and Services
Table 18. Pfizer Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. CNBG Basic Information, Manufacturing Base and Competitors
Table 20. CNBG Major Business
Table 21. CNBG Mono Vaccine Product and Services
Table 22. CNBG Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Pasteur MSD Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur MSD Major Business
Table 25. Sanofi Pasteur MSD Mono Vaccine Product and Services
Table 26. Sanofi Pasteur MSD Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 28. Serum Institute of India Major Business
Table 29. Serum Institute of India Mono Vaccine Product and Services
Table 30. Serum Institute of India Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Biokangtai Basic Information, Manufacturing Base and Competitors
Table 32. Biokangtai Major Business
Table 33. Biokangtai Mono Vaccine Product and Services
Table 34. Biokangtai Mono Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Mono Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Mono Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Mono Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Mono Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Mono Vaccine Production Site of Key Manufacturer
Table 40. Mono Vaccine New Entrant and Capacity Expansion Plans
Table 41. Mono Vaccine Mergers & Acquisitions in the Past Five Years
Table 42. Global Mono Vaccine Sales by Region (2017-2022) & (K Units)
Table 43. Global Mono Vaccine Sales by Region (2023-2028) & (K Units)
Table 44. Global Mono Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Mono Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. Global Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 48. Global Mono Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Mono Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Mono Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Mono Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Global Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Global Mono Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Mono Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Mono Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Mono Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Mono Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. North America Mono Vaccine Sales by Country (2023-2028) & (K Units)
Table 60. North America Mono Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Mono Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. North America Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 64. North America Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. North America Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Mono Vaccine Sales by Country (2017-2022) & (K Units)
Table 67. Europe Mono Vaccine Sales by Country (2023-2028) & (K Units)
Table 68. Europe Mono Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Mono Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 71. Europe Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 72. Europe Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 73. Europe Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Mono Vaccine Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Mono Vaccine Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Mono Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Mono Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 82. South America Mono Vaccine Sales by Country (2017-2022) & (K Units)
Table 83. South America Mono Vaccine Sales by Country (2023-2028) & (K Units)
Table 84. South America Mono Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Mono Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 87. South America Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 88. South America Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 89. South America Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Mono Vaccine Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Mono Vaccine Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Mono Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Mono Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Mono Vaccine Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Mono Vaccine Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Mono Vaccine Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Mono Vaccine Sales by Application (2023-2028) & (K Units)
Table 98. Mono Vaccine Raw Material
Table 99. Key Manufacturers of Mono Vaccine Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Mono Vaccine Typical Distributors
Table 103. Mono Vaccine Typical Customers
List of Figures
Figure 1. Mono Vaccine Picture
Figure 2. Global Mono Vaccine Revenue Market Share by Type in 2021
Figure 3. Meningococcal Vaccine
Figure 4. Japanese Encephalitis Vaccine
Figure 5. Yellow Fever Vaccine
Figure 6. Hepatitis Vaccine
Figure 7. Cholera Vaccine
Figure 8. Other
Figure 9. Global Mono Vaccine Revenue Market Share by Application in 2021
Figure 10. Adults
Figure 11. Children
Figure 12. Global Mono Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Mono Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Mono Vaccine Sales (2017-2028) & (K Units)
Figure 15. Global Mono Vaccine Price (2017-2028) & (USD/Unit)
Figure 16. Global Mono Vaccine Production Capacity (2017-2028) & (K Units)
Figure 17. Global Mono Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Mono Vaccine Market Drivers
Figure 19. Mono Vaccine Market Restraints
Figure 20. Mono Vaccine Market Trends
Figure 21. Global Mono Vaccine Sales Market Share by Manufacturer in 2021
Figure 22. Global Mono Vaccine Revenue Market Share by Manufacturer in 2021
Figure 23. Mono Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Mono Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Mono Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Mono Vaccine Sales Market Share by Region (2017-2028)
Figure 27. Global Mono Vaccine Revenue Market Share by Region (2017-2028)
Figure 28. North America Mono Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Europe Mono Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Mono Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. South America Mono Vaccine Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Mono Vaccine Revenue (2017-2028) & (USD Million)
Figure 33. Global Mono Vaccine Sales Market Share by Type (2017-2028)
Figure 34. Global Mono Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. Global Mono Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Global Mono Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. Global Mono Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Mono Vaccine Sales Market Share by Type (2017-2028)
Figure 40. North America Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 41. North America Mono Vaccine Sales Market Share by Country (2017-2028)
Figure 42. North America Mono Vaccine Revenue Market Share by Country (2017-2028)
Figure 43. United States Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Mono Vaccine Sales Market Share by Type (2017-2028)
Figure 47. Europe Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 48. Europe Mono Vaccine Sales Market Share by Country (2017-2028)
Figure 49. Europe Mono Vaccine Revenue Market Share by Country (2017-2028)
Figure 50. Germany Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Mono Vaccine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Mono Vaccine Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Mono Vaccine Revenue Market Share by Region (2017-2028)
Figure 59. China Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Mono Vaccine Sales Market Share by Type (2017-2028)
Figure 66. South America Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 67. South America Mono Vaccine Sales Market Share by Country (2017-2028)
Figure 68. South America Mono Vaccine Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Mono Vaccine Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Mono Vaccine Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Mono Vaccine Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Mono Vaccine Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Mono Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Mono Vaccine in 2021
Figure 80. Manufacturing Process Analysis of Mono Vaccine
Figure 81. Mono Vaccine Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
| 【モノワクチンについて】 モノワクチン（Mono Vaccine）は、特定の病原体やその一部を標的として作られたワクチンの一種です。このワクチンは、免疫系を刺激し、特定の疾患に対する免疫を誘導することを目的としており、主に感染症の予防に用いられます。モノワクチンの定義は、その名の通り、特定の一種類の抗原に基づいているため、通常は単一の病原体に対する免疫応答を引き起こすための製品を指します。 モノワクチンの特徴は、特定の病原体に対して強力な免疫応答を誘導することにあります。具体的には、抗体の生成を促進し、当該病原体が体内に侵入した際にすばやく反応できるようにするのです。このような応答は、「記憶細胞」と呼ばれる細胞により維持され、再度同じ病原体に感染した場合には迅速かつ効果的に対処することができます。 モノワクチンにはいくつかの種類が存在します。代表的なものとして、弱毒化生ワクチン、不活化ワクチン、サブユニットワクチンなどがあります。弱毒化生ワクチンは、病原体を弱めたものであり、通常はウイルスに使用されます。不活化ワクチンは、病原体を死滅させたものであり、細菌などに利用されます。サブユニットワクチンは、病原体の一部（たんぱく質や糖鎖）を利用して製造され、免疫応答を誘導します。 用途としては、多岐にわたります。例えば、インフルエンザワクチンや肝炎ワクチン、麻疹ワクチンなど、さまざまな感染症に対して広く用いられています。これらのワクチンは、接種することにより個人の免疫を強化し、また集団免疫を形成することによって、感染症の流行を防ぐ効果があります。 加えて、モノワクチンはワクチン接種プログラムにおいて非常に重要な役割を果たしています。特に、発展途上国においては、指定された病気に対するワクチン接種キャンペーンが行われており、こうしたキャンペーンの成果として多くの疾病の発生率が顕著に減少しています。また、ワクチンの普及は、医療経済においても重要な位置を占めています。予防接種による疾病の予防は医療コストの削減に寄与し、社会全体の健康を向上させる要因ともなっています。 モノワクチンの関連技術には、ワクチン開発に用いられる各種の技術が含まれます。アジュバント技術はその一例であり、ワクチンの効果を高めるために添加される物質です。アジュバントは、免疫系を強力に刺激する働きがあり、これによりワクチンの効能を向上させることができます。また、遺伝子組換え技術も広く用いられ、これにより特定の抗原を生産する細胞や微生物を用いてワクチンを製造することが可能です。 加速する技術革新により、モノワクチンの開発はさらに進化を遂げています。mRNAワクチンは最近の成功事例として挙げられ、特に新型コロナウイルス感染症（COVID-19）のパンデミックに際してその効果が証明されました。この技術は、病原体の遺伝情報を利用して体内で抗原を合成し、強力な免疫応答を引き出す仕組みです。mRNAワクチンは短期間での開発が可能で、従来のワクチンよりも製造プロセスが効率的であるため、今後のワクチン開発における新たなスタンダードになる可能性があります。 さらに、デリバリーシステムの向上もモノワクチンの効果を高める要因として挙げられます。ナノテクノロジーや微小カプセル技術を用いることで、ワクチン成分を効率的に体内に届けることができ、免疫応答を一層強化することが期待されています。 モノワクチンは、予防医学において欠かせない存在であり、将来的にも新しい抗原や技術を取り入れることで、さらなる進歩が期待されます。感染症の世界的な脅威に対抗する手段として、モノワクチンは重要な役割を果たし続け、私たちの健康を守るための基盤となるでしょう。今後の研究と開発が、この分野のさらなる革新と社会への貢献につながることを期待しています。 |